markets

Vocal Biomarkers: diagnostics through human voice

Words not only hurt, but now they can heal! Emotion, revealed through the imperceptible characteristics in voices could be used to diagnose certain conditions including stress,  depression and cardiovascular diseases. ‘Beyond Verbal’ have been investigating the links between sound and health for 21 years and are hopeful for this technology for the future and have produced an app.

 

February 17th, 2017|Research|0 Comments|

Accelerating access to new drugs in Japan

Writing in Nature Reviews Drug Discovery, Yasuhiro Fujiwara outlines developments in Japan to reduce the time required for new therapeutic drugs to gain marketing authorisation.

Fujiwara notes that Japan historically has taken longer than the United States and the European Union to give marketing approval for therapeutic drugs. Over the course of the last 20 years approval times have been […]

FTC Guidance – Marketing Your Mobile App: Get It Right from the Start

In the news this week:
The Federal Trade Commission, in partnership with the Office of National Coordinator for Health IT, the HHS Office for Civil Rights and the U.S. Food and Drug Administration, released an online tool this past week to give mobile app developers legal guidance for the development of their health products.
The FDA has limited regulatory oversight since […]

April 18th, 2016|Regulation|0 Comments|

Crowdacure, 3D Holograms and Phantom Limb Pain

Crowdacure is an interesting new website. A crowd sourcing site for underfunded and hard to fund medical research, one of the first projects is developing a new treatment using 3D holograms to relieve phantom limb pain.

Visual effects can trick the brain into believing that the lost limb is still there, resulting in pain relief.

The development of oral anticoagulants

Nature have released a short (5 min approx.) video on the development of oral anticoagulants. It is beautifully produced and informative.

March 3rd, 2016|Medicines|0 Comments|

Market prices, Market games

September 3: a paper in NEJM about drug companies claiming the First Amendment (free speech) to advertise drugs to patients beyond FDA regulation.

September 21: on The Guardian the news of a drug company raising the price 50 times (from $13.50 a pill to $750), and of Clinton’s campaign against it.

September 29: BBC Radio4 FileOn4 ‘Missing Medicines’ about the NHS […]

Sounds like a diagnosis?

We are used to seeing articles and research about smartphones and how helpful they can be for logging appointments, helping remember when to take medication, giving helpful information and so forth, but there are also apps which are designed to diagnose, too.

In an article in Nature, three such apps are detailed: ResApp, Priori and ApneaApp. The all use sound […]

On innovation, policies, economic returns – the cases of antibiotics , new and transformative drugs

In the current issue of Health Affairs :

February 2015; Volume 34, Issue 2 Biomedical Innovation
http://content.healthaffairs.org/content/34/2.toc

Outterson, K., J. H. Powers, G. W. Daniel and M. B. McClellan (2015). “Repairing The Broken Market For Antibiotic Innovation.” Health Affairs 34(2): 277-285. http://content.healthaffairs.org/content/34/2/277.abstract

“…Good public health practices curb inappropriate antibiotic use, making return on investment challenging in payment systems based on sales volume. We […]

The Farr Institute of Health Informatics and the ABPI Industry Forum

This conference was organised by The Farr Institute of Health Informatics Research in conjunction with The Association of the British Pharmaceutical Industry and the UK Health Informatics Research Network and was held on Tuesday 16th December 2014 at the Royal College of General Practitioners, 30 Euston Square in London. It was booked out, with just over 130 attendees from […]

On medicines supply – Drug shortages in European countries

A new paper on the problem of drug shortages and the sustainability of the medicine market:

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

by Kim Pauwels, Isabelle Huys, Minne Casteels and Steven Simoens
BMC Health Services Research, 2014, 14 :438

http://www.biomedcentral.com/1472-6963/14/438
Abstract

Background
Drug shortages are a global problem. While extensively studied in the United States, numbers about drug […]

October 1st, 2014|Regulation, Value|0 Comments|